Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Trastuzumab Deruxtecan + Neratinib for Cancer
Recruiting1 awardPhase 1
Duarte, California
This trial is testing the safety and effectiveness of combining neratinib with trastuzumab deruxtecan to treat patients with metastatic or unresectable solid tumors that have a change in the HER2 gene.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.